Search results
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 20 hours agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 1 day agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 2 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks via Yahoo Finance· 6 days agoZacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 2 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable...
Simply Wall St. via Yahoo Finance· 6 days agoKey Insights Institutions' substantial holdings in Novavax implies that they have significant...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 5 days agoYou'll find plenty of these stocks in the area of biotech and pharma -- let's check out three in...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 1 day agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 1 day agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...